31 Jan [43] COX-2 inhibitors update: Do journal publications tell the full story?
The COX-2 inhibitor story has evolved over a relatively short period of time, beginning with news of a ‘breakthrough’ class of drugs and evolving into concerns about cardiovascular toxicity.1 The story has potential implications for...